Chapter/Section Purchase

1 Study Coverage
1.1 Pandemic Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Whole Virus Vaccines
1.2.3 Split Virus Vaccines
1.2.4 Subunit Vaccines
1.3 Market by Application
1.3.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pandemic Influenza Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Pandemic Influenza Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Pandemic Influenza Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pandemic Influenza Vaccine Sales by Region
2.4.1 Global Pandemic Influenza Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Pandemic Influenza Vaccine by Region (2023-2028)
2.5 Global Pandemic Influenza Vaccine Revenue by Region
2.5.1 Global Pandemic Influenza Vaccine Revenue by Region (2017-2022)
2.5.2 Global Pandemic Influenza Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pandemic Influenza Vaccine Sales by Manufacturers
3.1.1 Global Top Pandemic Influenza Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pandemic Influenza Vaccine in 2021
3.2 Global Pandemic Influenza Vaccine Revenue by Manufacturers
3.2.1 Global Pandemic Influenza Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Pandemic Influenza Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pandemic Influenza Vaccine Revenue in 2021
3.3 Global Pandemic Influenza Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pandemic Influenza Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pandemic Influenza Vaccine Sales by Type
4.1.1 Global Pandemic Influenza Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Pandemic Influenza Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Pandemic Influenza Vaccine Revenue by Type
4.2.1 Global Pandemic Influenza Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Pandemic Influenza Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Pandemic Influenza Vaccine Price by Type
4.3.1 Global Pandemic Influenza Vaccine Price by Type (2017-2022)
4.3.2 Global Pandemic Influenza Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pandemic Influenza Vaccine Sales by Application
5.1.1 Global Pandemic Influenza Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Pandemic Influenza Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Pandemic Influenza Vaccine Revenue by Application
5.2.1 Global Pandemic Influenza Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Pandemic Influenza Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Pandemic Influenza Vaccine Price by Application
5.3.1 Global Pandemic Influenza Vaccine Price by Application (2017-2022)
5.3.2 Global Pandemic Influenza Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pandemic Influenza Vaccine Market Size by Type
6.1.1 North America Pandemic Influenza Vaccine Sales by Type (2017-2028)
6.1.2 North America Pandemic Influenza Vaccine Revenue by Type (2017-2028)
6.2 North America Pandemic Influenza Vaccine Market Size by Application
6.2.1 North America Pandemic Influenza Vaccine Sales by Application (2017-2028)
6.2.2 North America Pandemic Influenza Vaccine Revenue by Application (2017-2028)
6.3 North America Pandemic Influenza Vaccine Market Size by Country
6.3.1 North America Pandemic Influenza Vaccine Sales by Country (2017-2028)
6.3.2 North America Pandemic Influenza Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Pandemic Influenza Vaccine Market Size by Type
7.1.1 Europe Pandemic Influenza Vaccine Sales by Type (2017-2028)
7.1.2 Europe Pandemic Influenza Vaccine Revenue by Type (2017-2028)
7.2 Europe Pandemic Influenza Vaccine Market Size by Application
7.2.1 Europe Pandemic Influenza Vaccine Sales by Application (2017-2028)
7.2.2 Europe Pandemic Influenza Vaccine Revenue by Application (2017-2028)
7.3 Europe Pandemic Influenza Vaccine Market Size by Country
7.3.1 Europe Pandemic Influenza Vaccine Sales by Country (2017-2028)
7.3.2 Europe Pandemic Influenza Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pandemic Influenza Vaccine Market Size by Type
8.1.1 Asia Pacific Pandemic Influenza Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Pandemic Influenza Vaccine Market Size by Application
8.2.1 Asia Pacific Pandemic Influenza Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Pandemic Influenza Vaccine Market Size by Region
8.3.1 Asia Pacific Pandemic Influenza Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Pandemic Influenza Vaccine Market Size by Type
9.1.1 Latin America Pandemic Influenza Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Pandemic Influenza Vaccine Revenue by Type (2017-2028)
9.2 Latin America Pandemic Influenza Vaccine Market Size by Application
9.2.1 Latin America Pandemic Influenza Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Pandemic Influenza Vaccine Revenue by Application (2017-2028)
9.3 Latin America Pandemic Influenza Vaccine Market Size by Country
9.3.1 Latin America Pandemic Influenza Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Pandemic Influenza Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pandemic Influenza Vaccine Market Size by Type
10.1.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Pandemic Influenza Vaccine Market Size by Application
10.2.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Pandemic Influenza Vaccine Market Size by Country
10.3.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CSL
11.1.1 CSL Corporation Information
11.1.2 CSL Overview
11.1.3 CSL Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CSL Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Corporation Information
11.3.2 Sanofi Pasteur Overview
11.3.3 Sanofi Pasteur Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Pasteur Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Pasteur Recent Developments
11.4 Mylan
11.4.1 Mylan Corporation Information
11.4.2 Mylan Overview
11.4.3 Mylan Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylan Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AstraZeneca Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Overview
11.7.3 Johnson & Johnson Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Johnson & Johnson Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson & Johnson Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pandemic Influenza Vaccine Industry Chain Analysis
12.2 Pandemic Influenza Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pandemic Influenza Vaccine Production Mode & Process
12.4 Pandemic Influenza Vaccine Sales and Marketing
12.4.1 Pandemic Influenza Vaccine Sales Channels
12.4.2 Pandemic Influenza Vaccine Distributors
12.5 Pandemic Influenza Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pandemic Influenza Vaccine Industry Trends
13.2 Pandemic Influenza Vaccine Market Drivers
13.3 Pandemic Influenza Vaccine Market Challenges
13.4 Pandemic Influenza Vaccine Market Restraints
14 Key Findings in The Global Pandemic Influenza Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer